Literature DB >> 11085894

Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.

D M Araujo1, S R Cherry, K J Tatsukawa, T Toyokuni, H I Kornblum.   

Abstract

Functional imaging by repeated noninvasive scans of specific (18)F tracer distribution using a high-resolution small-animal PET scanner, the microPET, assessed the time course of alterations in energy utilization and dopamine receptors in rats with unilateral striatal quinolinic acid lesions. Energy utilization ipsilateral to the lesion, determined using scans of 2-deoxy-2-[(18)F]fluoro-d-glucose uptake, was compromised severely 1 week after intrastriatal excitotoxin injections. When the same rats were imaged 5 and 7 weeks postlesion, decrements in energy metabolism were even more prominent. In contrast, lesion-induced effects on dopamine D(2) receptor binding were more progressive, with an initial upregulation of [3-(2'-(18)F]fluoroethyl)spiperone binding apparent 1 week postlesion followed by a decline 5 and 7 weeks thereafter. Additional experiments revealed that marked upregulation of dopamine D(2) receptors consequent to quinolinic acid injections could be detected as early as 3 days after the initial insult. Postmortem markers of striatal GABAergic neurons were assessed in the same rats 7 weeks after the lesion: expression of glutamic acid decarboxylase and dopamine D(1) receptor mRNA, as well as [(3)H]SCH-23,390 and [(3)H]spiperone binding to dopamine D(1) and D(2) receptors, respectively, detected prominent decrements consequent to the lesion. In contrast, by 7 weeks postlesion [(3)H]WIN-35,428 binding to dopamine transport sites within the striatum appeared to be enhanced proximal to the quinolinic acid injection sites. The results demonstrate that functional imaging using the microPET is a useful technique to explore not only the progressive neurodegeneration that occurs in response to excitotoxic insults, but also to examine more closely the intricacies of neurotransmitter activity in a small animal model of HD. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085894     DOI: 10.1006/exnr.2000.7514

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  15 in total

Review 1.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

Review 2.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

3.  Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.

Authors:  Jitendriya Mishra; Anil Kumar
Journal:  Neurotox Res       Date:  2014-04-22       Impact factor: 3.911

4.  Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.

Authors:  Cindy Casteels; Emili Martinez; Guy Bormans; Lluïsa Camon; Núria de Vera; Veerle Baekelandt; Anna M Planas; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-03       Impact factor: 9.236

5.  Development of a simultaneous PET/microdialysis method to identify the optimal dose of 11C-raclopride for small animal imaging.

Authors:  Wynne K Schiffer; David L Alexoff; Colleen Shea; Jean Logan; Stephen L Dewey
Journal:  J Neurosci Methods       Date:  2004-12-08       Impact factor: 2.390

Review 6.  Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.

Authors:  Yilong Ma; David Eidelberg
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

7.  The possible role of the kynurenine pathway in anhedonia in adolescents.

Authors:  Vilma Gabbay; Benjamin A Ely; James Babb; Leonard Liebes
Journal:  J Neural Transm (Vienna)       Date:  2011-07-24       Impact factor: 3.575

8.  Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats.

Authors:  Harikesh Kalonia; Puneet Kumar; Anil Kumar; Bimla Nehru
Journal:  Inflammopharmacology       Date:  2009-07-26       Impact factor: 4.473

Review 9.  PET-based molecular imaging in neuroscience.

Authors:  A H Jacobs; H Li; A Winkeler; R Hilker; C Knoess; A Rüger; N Galldiks; B Schaller; J Sobesky; L Kracht; P Monfared; M Klein; S Vollmar; B Bauer; R Wagner; R Graf; K Wienhard; K Herholz; W D Heiss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-23       Impact factor: 9.236

10.  Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.

Authors:  Cindy Casteels; Erwin Lauwers; Guy Bormans; Veerle Baekelandt; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.